Skip to main content

Animations

MJFF Publications

1751 - 1760 of 6230 Results
Title
Year
  • Year
  • 2011
  • 2018
  • 2017
  • 2013
  • 2011
  • 2015
  • 2016
  • 2017
  • 2014
  • 2016
  • Summary Details
    OPEN
    Title: Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2010.08.228
    Citation Count: 133
  • Summary Details
    OPEN
    Title: CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jalz.2018.01.010
    Citation Count: 656
  • Summary Details
    OPEN
    Title: Genetic analysis of α‐synuclein 3′ untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2017.03.001
    Best OA location URL:
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Thalamic cholinergic innervation and postural sensory integration function in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awt247
    Citation Count: 173
  • Summary Details
    OPEN
    Title: Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1038/ncomms1453
    Citation Count: 445
  • Summary Details
    OPEN
    Title: Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/ncomms8314
    Citation Count: 280
  • Summary Details
    OPEN
    Title: Analysis of Mitochondrial haemoglobin in Parkinson's disease brain
    Journal Name: Mitochondrion
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.mito.2016.05.001
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
    Journal Name: The Lancet
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s0140-6736(17)31585-4
    Best OA location URL:
    Citation Count: 690
  • Summary Details
    OPEN
    Title: Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awu179
    Citation Count: 180
  • Summary Details
    OPEN
    Title: Loss-of-function mutations in theATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/aww307
    Citation Count: 152
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.